The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis
Penketh, A.R.; Hodson, M.E.; Batten, J.C.
British Journal of Clinical Practice 38(5): 188-189
1984
ISSN/ISBN: 0007-0947 PMID: 6610437 Document Number: 239257
Document emailed within 1 workday
Related Documents
Ciofu, O.; Pressler, T.; Pandey, J.P.; Høiby, N. 1997: The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients Clinical and Experimental Immunology 108(1): 88-94Lamblin, G.; Lhermitte, M.; Lafitte, J.J.; Filliat, M.; Degand, P.; Roussel, P. 1977: Comparative study of bronchial mucins isolated from the sputum of patients suffering from cystic fibrosis or other chronic bronchial diseases Bulletin Europeen de Physiopathologie Respiratoire 13(1): 175-190
De Meirleire, F.; Fauchere, J.L.; Simon, G. 1984: Pharmacokinetics and antibacterial activity of ticarcillin in 11 patients with cystic fibrosis Pathologie-Biologie 32(5 Part 2): 570-572
Stewardson-Krieger, P.; Naidu, S. 1981: Simultaneous recovery of beta-lactamase-negative and beta-lactamase-positive Haemophilus influenzae type b from cerebrospinal fluid of a neonate Pediatrics 68(2): 253-254
Bayraktar, B.; Toksoy, B.; Bulut, E. 2010: Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria Mikrobiyoloji Bulteni 44(2): 187-196
Baykal, A.; Cöplü, N.; Simşek, H.üs.; Esen, B.; Gür, D. 2012: The presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures Mikrobiyoloji Bulteni 46(2): 159-169
Kuga, A.; Yano, H.; Okamoto, R.; Sato, Y.; Miyata, A.; Inoue, M. 1999: Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria Japanese Journal of Antibiotics 52(9): 585-594
Jarlier, V. 1998: Beta-lactamase producers and other bacteria: which ones to take into consideration and when? the concept of beta-lactamase inhibitor Presse Medicale 27(Suppl 4): 17-18
Jacobs, M.R.; Aronoff, S.C.; Johenning, S.; Shlaes, D.M.; Yamabe, S. 1986: Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli Antimicrobial Agents and Chemotherapy 29(6): 980-985
Wiebicke, W.; Poynter, A.; Montgomery, M.; Pagtakhan, R. 1990: The effect of ipratropium bromide on lung function in patients with cystic fibrosis Pneumologie 44(Suppl 1): 277-278
Luder, E.; Gilbride, J.A. 1989: Teaching self-management skills to cystic fibrosis patients and its effect on their caloric intake Journal of the American Dietetic Association 89(3): 359-364
Wönne, R.; Plaut, G.; Posselt, H.G.; Stöver, B.; Hofmann, D.; Bender, S.W. 1984: The effect of mechanical percussion on lung function in patients with mild cystic fibrosis Praxis und Klinik der Pneumologie 38(3): 98-101
Tirouvanziam, R.; Desternes, M.; Saari, A.; Puchelle, E.; Péault, B.; Chinet, T. 1998: Bioelectric properties of human cystic fibrosis and non-cystic fibrosis fetal tracheal xenografts in SCID mice American Journal of Physiology 274(4): C875-C882
Denter, M.; Ramsay, M.; Jenkins, T. 1992: Cystic fibrosis. Part I. Frequency of the delta F508 mutation in South African families with cystic fibrosis South African Medical Journal 82(1): 7-10
Demikhovskaia, A.A.; Lukach, I.G.; Zaritskiĭ, A.M.; Kotov, A.I. 1984: A comparative analysis of beta-lactamase activity in enterobacteria Mikrobiolohichnyi Zhurnal 46(2): 36-39
Fernández Cuenca, F. 1998: Activity of beta-lactamase inhibitors against Acinetobacter baumannii Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 11(4): 384-385
Aver'ianova, E.V.; Bogacheva, T.I.; Rozhanskaia, T.I.; Selezneva, A.A. 1984: Rapid method of determining beta-lactamase inhibitor activity Antibiotiki 29(4): 245-248
Chen, C.H.; Yang, M.H.; Lin, J.S.; Lee, Y.C.; Perng, R.P. 1995: The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M. tuberculosis Proceedings of the National Science Council Republic of China. Part B Life Sciences 19(2): 80-84
Tawara, K.; Alvan, G.; Strandvik, B. 1984: Imbalance between alpha- and beta-adrenoceptor binding sites in marker cells in cystic fibrosis Research Communications in Chemical Pathology and Pharmacology 43(3): 515-518
Labia, R.; Thabaut, A.; Morand, A.; Tiwari, K.; Sirot, D.; Sirot, J. 1989: The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime Drugs under Experimental and Clinical Research 15(11-12): 535-540